Previous 10 | Next 10 |
SOUTH SAN FRANCISCO, Calif., July 16, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, and has a Phase 2 ready norovirus vaccine program, today announc...
Gainers: China Finance Online (NASDAQ: JRJC ) +176% . More news on: China Finance Online Co. Limited, Genetic Technologies Limited, WISeKey International Holding AG, Stocks on the move, , Read more ...
Moderna (NASDAQ: MRNA) and Vaxart (NASDAQ: VXRT) are two of the many companies that are pursuing a COVID-19 vaccine. The stock market has already produced a lot of riches for biotech investors in this sector; Moderna's stock has almost quadrupled in six months, while the s...
FinancialBuzz.com News Commentary New York, NY (7/15/2020) – The current pandemic has created the need for new technologies in order to improve population-level screening and patient monitoring. One sector that has emerged in recent years and spiked in popularity this year is telemedici...
Shares of Vaxart (NASDAQ: VXRT) rocketed 40% higher on Tuesday, furthering the biotech company's sharp ascent in recent days. On Monday, Vaxart's stock skyrocketed 52%, following bullish comments by B. Riley FBR analyst Mayank Mamtani. Mamtani began coverage of Vaxart and placed a buy rat...
IMV (NASDAQ: IMV ) +162% rallies on COVID-19 vaccine progress. More news on: IMV Inc., VolitionRx Limited, INmune Bio, Inc., Stocks on the move, , Read more ...
With participation based on interest received from RA Capital Management and Invus, Vaxart ( VXRT +59.3% ) raised ~$90M in gross proceeds through its At-the-Market (ATM) facility. More news on: Vaxart, Inc., , Healthcare stocks news, Stocks on the move, Read more ...
SOUTH SAN FRANCISCO, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that it has raised gross proceeds of approximately $90 millio...
Gainers: Equillium (NASDAQ: EQ ) +220% . More news on: Equillium, Inc., electroCore, Inc., WiMi Hologram Cloud Inc., Stocks on the move, , Read more ...
Shares of Vaxart (NASDAQ: VXRT) were skyrocketing 26.4% higher as of 11:22 a.m. EDT on Monday. The huge jump came after investment bank B. Riley FBR initiated coverage on the stock with a buy rating and a price target of $22. This price target represented a 176% premium over Vaxart's closing...
News, Short Squeeze, Breakout and More Instantly...
Vaxart, Inc. (NASDAQ:VXRT) reported its first-quarter financial results after the bell Monday. Here's a look at the details. The Details...
Positive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart’s oral pill XBB COVID-19 vaccine a...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...